RACHAEL SCHWAIT: Open Payments
NPI 1184998114 · FURLONG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$708 in 27 payments from 13 companies in 2025. Trend: 2023 $232 · 2024 $588 · 2025 $708
Food & beverage: $603Education: $105
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 4 | $188 |
| Janssen Biotech, Inc. | 4 | $157 |
| ABBVIE INC. | 3 | $71 |
| PFIZER INC. | 3 | $61 |
| Lilly USA, LLC | 3 | $56 |
| Verrica Pharmaceuticals Inc. | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| GENZYME CORPORATION | 1 | $22 |
| LEO Pharma Inc. | 1 | $21 |
| Galderma Laboratories, L.P. | 1 | $17 |
Products named: DUPIXENT, TREMFYA, CIBINQO, SKYRIZI, YCANTH, TALTZ, Sotyktu, ADBRY.
Industry payments across PA — which companies pay providers there.
